세계의 로봇 지원 신경외과 시스템 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedCore

The global robotic-assisted neurosurgery system market was valued at approximately $130 million in 2024 and is projected to grow at a CAGR of 14.5%, reaching less than $330 million by 2031.

The market is segmented into:

• Capital Equipment
• Services & Maintenance Revenue

Market Insights & Data Coverage

• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Landscape, Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends & Growth Drivers

• Benefits of Robotic-Assisted Neurosurgery

* Minimally invasive procedures, leading to:

* Higher accuracy

* Shorter recovery times

* Fewer complications & revisions

* Lower hospital stays and costs

• Expanding range of procedures due to robotic advancements.
• Challenges & Market Limitations

* High system costs & training requirements

* Learning curve for surgeons - mastery requires extensive training and multiple procedures.

* Surgeon adoption rate may limit growth in certain regions.

Geographic Trends & Growth Projections

• North America had the largest market share in 2024, followed by Western Europe and Asia-Pacific.
• Asia-Pacific is expected to grow at the fastest rate compared to other major regions.
• Africa had the smallest market share in 2024 but is projected to have the highest CAGR among all regions.
• All regions are expected to maintain double-digit CAGR through 2031.

Market Share Insights

Leading Competitors & Key Developments

1 Zimmer Biomet - Market Leader

* Offers ROSA(R) ONE Brain, part of the ROSA(R) robotics portfolio for neurosurgery.

2 Synaptive Medical - Second-Largest Player

* Provides the Brightmatter(TM) product line and Modus V(TM), a robotic microscope.

* The Brightmatter(TM) line includes Brightmatter(TM) Plan and Guide, used alongside Modus V(TM).

3 Medtronic - Third-Largest Player

* Offers Stealth Autoguide(TM), a cranial robotic platform.

* FDA-approved in December 2019 and actively expanding market reach.

Market Segmentation Summary

• Capital Equipment Market
• Services & Maintenance Revenue Market

Global Research Scope

• Regions Covered

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia-Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

• Base Year: 2025
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size, Market Shares
• Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices
• Procedure Numbers

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends & Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls, Disruptive Technologies
• Disease Overviews

Data Sources

• Primary Interviews with Industry Leaders
• Government Physician & Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database

TABLE OF CONTENT

• 13.1 Executive Summary
  • 13.1.1 Global Robotic-Assisted Neurosurgery System Market Overview
  • 13.1.2 Competitive Analysis
  • 13.1.3 Market Segmentation
  • 13.1.4 Regions Included
• 13.2 Introduction
• 13.3 Procedure Numbers
• 13.4 Market Overview
  • 13.4.1 By Segment
  • 13.4.2 By Region
• 13.5 Market Analysis and Forecast
  • 13.5.1 System Placement
  • 13.5.2 Robotic-Assisted Neurosurgery Capital Equipment Market
  • 13.5.3 Robotic-Assisted Neurosurgery System Service and Maintenance Revenue Market
• 13.6 Drivers and Limiters
  • 13.6.1 Market Drivers
  • 13.6.2 Market Limiters
• 13.7 Competitive Market Share Analysis